Understanding how inflammasomes activate a key protein involved in inflammation.
Caspase-1 Activation by the Inflammasomes
This study is looking at how certain proteins in your body respond to damage and infections, which could help us understand and find new treatments for inflammatory diseases like arthritis and type 2 diabetes.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Thomas Jefferson University NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11083744 on NIH RePORTER |
What this research studies
This research investigates the role of inflammasomes, which are protein complexes that activate caspase-1 in response to tissue damage and infections. By studying how caspase-1 processes inactive forms of inflammatory cytokines, the research aims to uncover mechanisms that lead to various inflammatory diseases, including arthritis and type 2 diabetes. The approach involves examining the signals that trigger inflammasome activation and how these processes can contribute to disease. Patients may benefit from insights that could lead to new treatments targeting these inflammatory pathways.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals suffering from inflammatory conditions such as arthritis, type 2 diabetes, or atherosclerosis.
Not a fit: Patients with non-inflammatory conditions or those not affected by the diseases being studied may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that better manage or prevent inflammatory diseases.
How similar studies have performed: Previous research has shown success in targeting inflammasome pathways for therapeutic interventions, indicating potential for impactful findings in this area.
Where this research is happening
Philadelphia, United States
- Thomas Jefferson University — Philadelphia, United States (Active)
Researchers
- Principal investigator: Alnemri, Emad S — Thomas Jefferson University
- Study coordinator: Alnemri, Emad S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.